Controlled-Release Carbamazepine Granules and Tablets Comprising Lipophilic and Hydrophilic Matrix Components
- 9 October 2008
- journal article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 9 (4) , 1054-1062
Abstract
The objective of this study was to investigate the effect of lipophilic (Compritol® 888 ATO) and hydrophilic components (combination of HPMC and Avicel) on the release of carbamazepine from granules and corresponding tablet. Wet granulation followed by compression was employed for preparation of granules and tablets. The matrix swelling behavior was investigated. The dissolution profiles of each formulation were compared to those of Tegretol® CR tablets and the mean dissolution time (MDT), dissolution efficiency (DE %) and similarity factor (f 2 factor) were calculated. It was found that increase in the concentration of HPMC results in reduction in the release rate from granules and achievement of zero-order is difficult from the granules. The amount of HPMC plays a dominant role for the drug release. The release mechanism of CBZ from matrix tablet formulations follows non-Fickian diffusion shifting to case II by the increase of HPMC content, indicating significant contribution of erosion. Increasing in drug loading resulted in acceleration of the drug release and in anomalous controlled-release mechanism due to delayed hydration of the tablets. These results suggest that wet granulation followed by compression could be a suitable method to formulate sustained release CBZ tablets.Keywords
This publication has 28 references indexed in Scilit:
- In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tabletsInternational Journal of Pharmaceutics, 2006
- The effect of hydrophilic and lipophilic polymers and fillers on the release rate of atenolol from HPMC matricesIl Farmaco, 2004
- Mechanistic analysis of protein delivery from porous poly(vinyl alcohol) systemsJournal of Drug Delivery Science and Technology, 2004
- Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenateEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001
- Effect of the nature of the polymer and of the process of drug release (diffusion or erosion) for oral dosage formsComputational and Theoretical Polymer Science, 2000
- Formulation and Release Behavior of Diclofenac Sodium in Compritol 888 Matrix Beads Encapsulated in AlginateDrug Development and Industrial Pharmacy, 2000
- Compritol® 888 ATO: an innovative hot-melt coating agent for prolonged-release drug formulationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 1999
- Sustained release from matrix system comprising hydrophobia and hydrophilic (gel-forming) partsInternational Journal of Pharmaceutics, 1991
- Hydrogels for controlled drug deliveryBiomaterials, 1984
- Controlled release of water-soluble macromolecules from bioerodible hydrogelsBiomaterials, 1983